LICENSE agreementLicense Agreement • March 25th, 2020 • Viela Bio, Inc. • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (the “Agreement”) is effective as of October 8, 2019 (hereinafter called “Effective Date”), between Viela Bio, Inc., a Delaware corporation with a principal place of business at One MedImmune Way, Gaithersburg MD, 20878, U.S.A. (“Viela”) and Mitsubishi Tanabe Pharma Corporation organized and existing under the laws of Japan with a principal place of business at 3-2-10, Dosho-machi, Chuo-ku, Osaka 541-8505, Japan (“MTPC”). Viela and MTPC may each be referred to herein individually as a “Party” and collectively as the “Parties.”
